HIV/AIDS

Genvoya Labeling Updated with Interaction, Long-Term Study Data

By August 16, 2017

Under drug interactions, new clinical comments regarding concomitant systemic/inhaled/nasal/ophthalmic corticosteroids have been added.

Fixed-Dose, Single-Tablet HIV Regimen Granted Priority Review

By August 14, 2017

The investigational fixed-dose treatment combines bictegravir (BIC) 50mg, a novel integrase strand transfer inhibitor (INSTI), with emtricitabine (FTC) 200mg and tenofovir alafenamide (TAF) 25mg, a dual-NRTI backbone.

Teens Find Vaginal Ring for HIV Prevention Acceptable

By July 26, 2017

Previous Phase 3 studies enrolling >4,500 women (ASPIRE and The Ring Study) have already demonstrated the vaginal ring to be safe and effective in protecting women aged 18-45 years against HIV.

Doravirine Comparable to Efavirenz in Combination with Other ART for HIV

By July 26, 2017

Doravirine is being investigated in other Phase 3 trials including DRIVE-AHEAD, DRIVE-FORWARD, and DRIVE-SHIFT.

Vaccine Regimens Generate Anti-HIV Immune Responses in Early-Stage Trial

By July 26, 2017

The early-stage clinical trial studied "mosaic" vaccines created to induce immune responses against various HIV subtypes responsible for infections across the world.

HIV Prevention Among HIV-Discordant Couples Trying to Conceive

By June 01, 2017

A review of recent data showed that insemination with sperm from an HIV-negative donor is the safest option for a discordant couple where the woman does not have HIV but the man is HIV-positive.

Isentress HD Provides New Option in HIV Treatment

By May 30, 2017

Isentress HD is a 1200mg once-daily dose that is given orally as two 600mg tablets with or without food.

Resurgence in Unsafe Sex Practices Tied to Belief that HIV Tx Reduces Risk

February 14, 2017

Researchers report increased beliefs that treatments prevent HIV and increased condomless anal sex

Patient Infected with HIV Despite Long-Term PrEP

February 02, 2017

43-year-old man infected with strain of HIV that has become resistant to Truvada

The HIV Treatment Continuum: Recommendations for Improving Future Outcomes

By November 30, 2016

An estimated 70% of US persons living with HIV are not virally suppressed.